Kenvue Inc. (FRA:J4D)

Market Cap	28.36B -25.5%
Revenue (ttm)	12.86B -2.1%
Net Income	1.25B +42.7%
EPS	0.65 +41.3%
Shares Out	n/a
PE Ratio	22.70
Forward PE	15.18
Dividend	0.71 (4.86%)
Ex-Dividend Date	Feb 11, 2026

Volume	n/a
Average Volume	129
Open	14.49
Previous Close	14.72
Day's Range	14.49 - 14.55
52-Week Range	11.83 - 22.21
Beta	n/a
RSI	44.79
Earnings Date	May 7, 2026

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral a...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2022
• Employees: 21,890
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: J4D

Financial Performance

In 2025, Kenvue's revenue was $15.12 billion, a decrease of -2.14% compared to the previous year's $15.46 billion. Earnings were $1.47 billion, an increase of 42.72%.

Financial numbers in USD